Mouse as a model of growth retardation in cystic fibrosis

Pediatric Research

Volumn 59, Issue 2, 2006, Pages 191-195

  Rosenberg, Lewis A ^a   Schluchter, Mark D ^b   Parlow, Albert F ^c   Drumm, Mitchell L ^a,b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C; TRANSMEMBRANE CONDUCTANCE REGULATOR; PRIMER DNA;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; BODY HEIGHT; BODY WEIGHT; CFTR GENE; CYSTIC FIBROSIS; DISEASE SEVERITY; ENTEROPATHY; FEMALE; FOOD INTAKE; GENE; GENE MUTATION; GENOTYPE; GROWTH HORMONE BLOOD LEVEL; GROWTH RETARDATION; LUNG INSUFFICIENCY; MALABSORPTION; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PREMATURITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYMPTOMATOLOGY; WILD TYPE; ANIMAL; BLOOD; DISEASE MODEL; FEEDING BEHAVIOR; GENETICS; GROWTH DISORDER; METABOLISM; MUTATION; PATHOPHYSIOLOGY; POLYMERASE CHAIN REACTION;

ANIMALS; BASE SEQUENCE; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; DISEASE MODELS, ANIMAL; DNA PRIMERS; FEEDING BEHAVIOR; GROWTH DISORDERS; GROWTH HORMONE; INSULIN-LIKE GROWTH FACTOR I; MICE; MUTATION; POLYMERASE CHAIN REACTION;

EID: 33646689607     PISSN: 00313998     EISSN: None     Source Type: Journal    
DOI: 10.1203/01.pdr.0000196720.25938.be     Document Type: Article

References (40)

1. Lai HC, Kosorok MR, Sondel SA, Chen ST, FitzSimmons SC, Green CG, Shen G, Walker S, Farrell PM 1998 Growth status in children with cystic fibrosis based on the National Cystic Fibrosis Patient Registry data: evaluation of various criteria used to identify malnutrition. J Pediatr 132:478-485
2. Zemel BS, Jawad AF, FitzSimmons S, Stallings VA 2000 Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry. J Pediatr 137:374-380
3. Konstan MW, Butler SM, Wohl ME, Stoddard M, Matousek R, Wagener JS, Johnson CA, Morgan WJ, Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis 2003 Growth and nutritional indexes in early life predict pulmonary function in cystic fibrosis. J Pediatr 142:624-630.
4. Hardin DS, Ellis KJ, Dyson M, Rice J, McConnell R, Seilheimer DK 2001 Growth hormone improves clinical status in prepubertal children with cystic fibrosis: results of a randomized controlled trial. J Pediatr 139:636-642
5. Hardin DS 2004 GH improves growth and clinical status in children with cystic fibrosis - a review of published studies. Eur J Endocrinol 151:S81-S85
6. Pencharz PB, Durie PR 2000 Pathogenesis of malnutrition in cystic fibrosis, and its treatment. Clin Nutr 19:387-394
7. Hankard R, Munck A, Navarro J 2002 Nutrition and growth in cystic fibrosis. Horm Res 58:16-20
8. Shapiro BL 1989 Evidence for a mitochondrial lesion in cystic fibrosis. Life Sci 44:1327-1334
9. Stutts MJ, Knowles MR, Gatzy JT, Boucher RC 1986 Oxygen consumption and ouabain binding sites in cystic fibrosis nasal epithelium. Pediatr Res 20:1316-1320
10. Mulberg AE, Weyler RT, Altschuler SM, Hyde TM 1998 Cystic fibrosis transmembrane conductance regulator expression in human hypothalamus. Neuroreport 9:141-144
11. Weyler RT, Yurko-Mauro KA, Rubenstein R, Kollen WJ, Reenstra W, Altschuler SM, Egan M, Mulberg AE 1999 CFTR is functionally active in GnRH-expressing GT1-7 hypothalamic neurons. Am J Physiol 277:C563-C571
12. Ahme ML, Ong KK, Thomson AH, Dunger DB 2004 Reduced gains in fat and fat-free mass, and elevated leptin levels in children and adolescents with cystic fibrosis. Acta Paediatr 93:1185-1191
13. Stettler N, Kawchak DA, Boyle LL, Propert KJ, Scanlin TF, Stallings VA, Zemel BS 2000 Prospective evaluation of growth, nutritional status, and body composition in children with cystic fibrosis. Am J Clin Nutr 72:407-413
14. Zeiher BG, Eichwald E, Zabner J, Smith JJ, Puga AP, McCray PB Jr., Capecchi MR, Welsh MJ, Thomas KR 1995 A mouse model for the delta F508 allele of cystic fibrosis. J Clin Invest 96:2051-2064
15. Snouwaert JN, Brigman KK, Latour AM, Malouf NN, Boucher RC, Smithies O. Koller BH 1992 An animal model for cystic fibrosis made by gene targeting. Science 257:1083-1088
16. Scholte BJ, Davidson DJ, Wilke M, De Jonge HR 2004 Animal models of cystic fibrosis. J Cyst Fibros 3:183-190
17. Grubb BR, Boucher RC 1999 Pathophysiology of gene-targeted mouse models for cystic fibrosis. Physiol Rev 79:S193-S214
18. Clarke LL, Grubb BR, Gabriel SE, Smithies O, Koller BH, Boucher RC 1992 Defective epithelial chloride transport in a gene-targeted mouse model of cystic fibrosis. Science 257:1125-1128
19. Clarke LL, Gawenis LR, Franklin CL, Harline MC 1996 Increased survival of CFTR knockout mice with an oral osmotic laxative. Lab Anim Sci 46:612-618
20. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45-
21. Lupu F, Terwilliger JD, Lee K, Segre GV, Efstratiadis A 2001 Roles of growth hormone and insulin-like growth factor 1 in mouse postnatal growth. Dev Biol 229:141-162
22. Yakar S, Liu JL, Stannard B, Butler A, Accili D, Sauer B, LeRoith D 1999 Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A 96:7324-7329
23. Sjogren K, Liu JL, Blad K, Skrtic S, Vidal O, Wallenius V, LeRoith D, Tornell J, Isaksson OG, Jansson JO, Ohlsson C 1999 Liver-derived insulin-like growth factor I (IGF-I) is the principal source of IGF-I in blood but is not required for postnatal body growth in mice. Proc Natl Acad Sci U S A 96:7088-7092
24. Park S, Sohn S, Kineman RD 2004 Fasting-induced changes in the hypothalamic-pituitary-GH axis in the absence of GH expression: lessons from the spontaneous dwarf rat. J Endocrinol 180:369-378
25. Ortiz-Caro J, Gonzalez C, Jolin T 1984 Diurnal variations of plasma growth hormone, thyrotropin, thyroxine, and triiodothyronine in streptozotocin-diabetic and food-restricted rats. Endocrinology 115:2227-2232
26. Sohlstrom A, Katsman A, Kind KL, Grant PA, Owens PC, Robinson JS, Owens JA 1998 Effects of acute and chronic food restriction on the insulin-like growth factor axis in the guinea pig. J Endocrinol 157:107-114
27. Laursen EM, Juul A, Lanng S, Hoiby N, Koch C, Muller J, Skakkebaek NE 1995 Diminished concentrations of insulin-like growth factor I in cystic fibrosis. Arch Dis Child 72:494-497
28. Laursen EM, Lanng S, Rasmussen MH, Koch C, Skakkebaek NE, Muller J 1999 Normal spontaneous and stimulated GH levels despite decreased IGF-I concentrations in cystic fibrosis patients. Eur J Endocrinol 140:315-321
29. Taylor AM, Bush A, Thomson A, Oades PJ, Marchant JL, Bruce-Morgan C, Holly J, Ahmed L, Dunger DB 1997 Relation between insulin-like growth factor-I, body mass index, and clinical status in cystic fibrosis. Arch Dis Child 76:304-309
30. Davidson DJ, Rolfe M 2001 Mouse models of cystic fibrosis. Trends Genet 17:S29-S37
31. Durie PR, Kent G, Phillips MJ, Ackerley CA 2004 Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model. Am J Pathol 164:1481-1493
32. Ip WF, Bronsveld I, Kent G, Corey M, Durie PR 1996 Exocrine pancreatic alterations in long-lived surviving cystic fibrosis mice. Pediatr Res 40:242-249
33. Coschigano KT, Holland AN, Riders ME, List EO, Flyvbjerg A, Kopchick JJ 2003 Deletion, but not antagonism, of the mouse growth hormone receptor results in severely decreased body weights, insulin, and insulin-like growth factor I levels and increased life span. Endocrinology 144:3799-3810
34. Butler AA, Le Roith D 2001 Control of growth by the somatropic axis: growth hormone and the insulin-like growth factors have related and independent roles. Annu Rev Physiol 63:141-164
35. Scacchi M, Ida Pincelli A, Cavagnini F 2003 Nutritional status in the neuroendocrine control of growth hormone secretion: the model of anorexia nervosa. Front Neuroendocrinol 24:200-224
36. Bijvelds MJ, Bronsveld I, Havinga R, Sinaasappel M, de Jonge HR, Verkade HJ 2005 Fat absorption in cystic fibrosis mice is impeded by defective lipolysis and post-lipolytic events. Am J Physiol Gastrointest Liver Physiol 288:G646-G653
37. Levy E, Gurbindo C, Lacaille F, Paradis K, Thibault L, Seidman E 1993 Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis. Pediatr Res 34:162-166
38. Nixon LS, Yung B, Bell SC, Elborn JS, Shale DJ 1998 Circulating immunoreactive interleukin-6 in cystic fibrosis. Am J Respir Crit Care Med 157:1764-1769
39. Norkina O, Kaur S, Ziemer D, De Lisle RC 2004 Inflammation of the cystic fibrosis mouse small intestine. Am J Physiol Gastrointest Liver Physiol 286:G1032-G1041
40. De Benedetti F, Alonzi T, Moretta A, Lazzaro D, Costa P, Poli V, Martini A, Ciliberto G, Fattori E 1997 Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 99:643-650